RNS Number:7255A
CardioMag Imaging, Inc.
24 July 2007


24 July 2007


                            CardioMag Imaging, Inc.


                           Results of Special Meeting


CardioMag Imaging, Inc. (the "Company") announces that at the Special Meeting on
Friday 20 July 2007 shareholders approved the cancellation of Admission of the
Company's shares to trading on AIM, the amendment of the Company's Certificate
of Incorporation and By-Laws to remove certain restrictive provisions, and to
effect a reverse stock split of all shares of the Company's common stock
pursuant to which twenty shares of the Company's common stock would be combined
into one share of its common stock.


The per cent of votes cast for the resolutions were as follows:

Proposal 1 - To approve cancellation of admission of the company's shares to
trading on the alternative investment market (AIM) of the London Stock Exchange

For                                                                        98%

Proposal 2 - To approve amendments to our certificate of incorporation and by-
laws to remove certain provisions and to effect a 20-to-1 reverse stock of all
shares of the company's common stock

For                                                                        96%


The last day of trading of CardioMag Imaging Shares on AIM is anticipated to be
3 August 2007. Once the Admission to trading on AIM has been cancelled the
Company will commence the stock split. The Company will advise shareholders at a
later time as to when the new share certificates will be distributed.


For further information please contact:

Carl Rosner, CardioMag Imaging, Inc. +1 518 381 1000

Simon Leathers, Evolution Securities Limited +44 (0) 207 071 4315


CardioMag Imaging Inc., incorporated under the laws of Delaware, is a
development stage company, which produces magnetocardiographs (MCGs) unique
diagnostic tools for Cardiologists. MCGs are used to measure the magnetic fields
generated by the heart's electrical activity, allowing physicians to identify
abnormal cardiac conduction distributions as well as the presence of ischemia
resulting from inadequate blood supply to the heart.



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
ROMSELFWDSWSEIW
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Optibiotix Health Charts.
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Optibiotix Health Charts.